Longevity PapersAbout
← All papers
RESEARCH PAPER / 2024-09-20

Sarcopenia as a risk factor for hypertension.

Ayumi Toba, Joji Ishikawa

Department of Cardiology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan. [email protected]. · pubmed

Abstract

Sarcopenia, defined as progressive loss of muscle mass, function, and strength is an aging-related disease that share common pathophysiology with frailty. Sarcopenia is one of the risk factors of hypertension. Insulin resistance, oxidative stress, imbalance of catabolism and anabolism, and chronic inflammation are the underlying mechanisms that explain the association between hypertension and sarcopenia. Exercise is beneficial for older hypertensive patients in prevention of sarcopenia and improvement to normal state. It also attributes to cardiovascular risk reduction and prevention of falls. In this review article, we summarize latest issues about sarcopenia and exercise.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper discusses the relationship between sarcopenia and hypertension, both of which are age-related conditions. While it highlights the importance of exercise in mitigating these issues, it primarily focuses on treating symptoms rather than addressing the root causes of aging. The findings contribute to the understanding of sarcopenia and its implications for older adults, but the overall impact on the field of longevity research is limited.

Author of this paper? Send a correction.